Search
Publication
Communicable disease threats report, 16 July - 23 July, week 29
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9 July - 15 July 2017 and includes updates on measles, influenza A(H7N9), poliomyelitis, West Nile fever, rubella, salmonella and cyclosporiasis.
Publication
Communicable disease threats report, 4 June - 10 June 2017, week 23
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 June - 10 June 2017 and includes updates on hepatitis A, measles, Ebola virus disease, MERS, influenza A(H7N9), yellow fever, Legionnaires' disease and West Nile fever.
Publication
Communicable disease threats report, 14 May - 20 May 2017, week 20
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14 May - 20 May 2017 and includes updates on influenza, measles, hepatitis A, cholera, polio, Ebola virus disease and Legionnaires' disease.
- Avian influenza virus
- China
- Cholera
- Democratic Republic of the Congo
- Ebola haemorrhagic fever
- Emerging and Vector-borne Diseases Programme
- EU/EEA
- Europe
- Food- and Waterborne Diseases and Zoonoses Programme
- Hepatitis A
- Influenza
- Influenza and other Respiratory Viruses Programme
- Legionnaires’ disease
- Measles
- Netherlands
- Poliomyelitis
- Programme on HIV, Sexually Transmitted Infections and viral Hepatitis
- Public health threat
- Surveillance
- United Arab Emirates
- Zoonotic influenza
News
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt, 9 April 2015
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt
Publication
Rapid risk assessment: A(H5N1) Highly Pathogenic Avian Influenza in Egypt – Implications for human health in Europe
Highly pathogenic avian influenza A(H5N1) infections are continuing to occur in poultry and humans in Egypt. However there is no evidence of a significant change in the pattern of human illness and deaths related to A(H5N1) virus infections in the country. Certainly there are no epidemiological data or analyses consistent with adaptation of these viruses to humans.